OTC Markets Group Appoints JP Chan to Lead Asia-Pacific Growth in Hong Kong
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group (OTCQX: OTCM), operator of regulated ma…

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
No analyst coverage available for this stock.
Trend
-2.4% vs SMA 50 · +1126.8% vs SMA 200
Momentum
NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group (OTCQX: OTCM), operator of regulated ma…

PRA is one of the world's leading global contract research organizations by revenue, providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. PRA's global clinical development platform includes more than 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East and more than 18,100 employees worldwide. Since 2000, PRA has participated in approximately 4,200 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 100 drugs.